Amundi »

Catalyst Pharmaceutical Partners shares owned by Amundi

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Amundi from 13F filings

Historical chart of Amundi investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Amundi consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Amundi

Quarter filed Position value Share count Share price at filing
2023-12-31 $201k 13k 15.29
2023-09-30 $160k 13k 12.78
2023-06-30 $160k 13k 12.76

More positions owned by Amundi

Apple (AAPL)
Amazon Commstck (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Adobe Systems Incorporated (ADBE)
Advanced Micro Devices Commstck (AMD)
Stellantis SHS (STLA)
Home Depot (HD)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Mastercard Cl A (MA)
Exxon Mobil Corporation (XOM)
Chevron Corporation (CVX)

View all positions for Amundi

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
LSV Asset Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners